- Home
- LPA vs BDTX Comparison
LPA vs BDTX Comparison
Compare LPA & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPA
- BDTX
- Stock Information
- Founded
- LPA 2013
- BDTX 2014
- Country
- LPA United States
- BDTX United States
- Employees
- LPA N/A
- BDTX N/A
- Industry
- LPA
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LPA
- BDTX Health Care
- Exchange
- LPA Nasdaq
- BDTX Nasdaq
- Market Cap
- LPA 196.1M
- BDTX 181.4M
- IPO Year
- LPA N/A
- BDTX 2020
- Fundamental
- Price
- LPA $6.31
- BDTX $3.16
- Analyst Decision
- LPA
- BDTX Strong Buy
- Analyst Count
- LPA 0
- BDTX 6
- Target Price
- LPA N/A
- BDTX $12.50
- AVG Volume (30 Days)
- LPA 10.2K
- BDTX 840.0K
- Earning Date
- LPA 11-12-2025
- BDTX 11-04-2025
- Dividend Yield
- LPA N/A
- BDTX N/A
- EPS Growth
- LPA N/A
- BDTX N/A
- EPS
- LPA 0.22
- BDTX 0.25
- Revenue
- LPA $45,924,457.00
- BDTX $70,000,000.00
- Revenue This Year
- LPA N/A
- BDTX N/A
- Revenue Next Year
- LPA N/A
- BDTX N/A
- P/E Ratio
- LPA $29.31
- BDTX $12.78
- Revenue Growth
- LPA 6.18
- BDTX N/A
- 52 Week Low
- LPA $5.71
- BDTX $1.20
- 52 Week High
- LPA $15.85
- BDTX $6.23
- Technical
- Relative Strength Index (RSI)
- LPA 49.52
- BDTX 58.90
- Support Level
- LPA $6.10
- BDTX $3.13
- Resistance Level
- LPA $6.62
- BDTX $3.43
- Average True Range (ATR)
- LPA 0.25
- BDTX 0.18
- MACD
- LPA 0.01
- BDTX 0.02
- Stochastic Oscillator
- LPA 52.31
- BDTX 63.51
About LPA Logistic Properties of the Americas
Logistic Properties of the Americas is a fully-integrated, internally managed real estate company that develops, owns, and manages a diversified portfolio of warehouse logistics assets in Central America and South America. It focuses on modern Class A logistics real estate in high-growth and high-barrier-to-entry markets that are undersupplied and have low penetration rates. The company has three operating segments, based on geographic regions, consisting of Colombia, Peru, and Costa Rica. The company generates the majority of its revenue from the Costa Rica geographical segment.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.